Publication:
Should the trigger to oocyte retrieval interval be different in progestin-primed ovarian stimulation cycles?

dc.contributor.kuauthorAta, Mustafa Barış
dc.contributor.kuauthorÇakar, Aysu
dc.contributor.kuauthorTürkgeldi, Engin
dc.contributor.kuauthorYıldız, Şule
dc.contributor.kuauthorKeleş, İpek
dc.contributor.kuauthorKalafat, Erkan
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.date.accessioned2024-12-29T09:39:34Z
dc.date.issued2023
dc.description.abstractResearch question: Does the trigger to oocyte retrieval interval (TORI) affect oocyte maturation rates differently in progestinprimed ovarian stimulation (PPOS) and gonadotrophin-releasing hormone (GnRH) antagonist cycles? Design: This was a retrospective cohort study. The interaction between the stimulation protocol and TORI was assessed in a linear mixed effects multivariable regression analysis with oocyte maturation rate as the dependent variable, and stimulation protocol (GnRH antagonist or PPOS), age (continuous), gonadotrophin type (FSH or human menopausal gonadotrophin), trigger (human chorionic gonadotrophin [HCG] or GnRH agonist), TORI (continuous) and days of stimulation (continuous) as the independent variables. Oocyte maturation rate was defined as number of metaphase II oocytes/number of cumulus oocyte complexes retrieved. The maturation rate was calculated per cycle and treated as a continuous variable. Results: A total of 473 GnRH antagonist and 205 PPOS cycles (121 conventional PPOS and 84 flexible PPOS) were analysed. The median (quartiles) female age was 36 (32 40) years. Of these cycles, 493 were triggered with HCG and 185 with a GnRH agonist. The TORIranged between 33.6 and 39.1 h, with a median (quartiles) of 36.2 (36 36.4) hours. Maturation rates were similar between fixed PPOS, flexible PPOS and antagonist cycles (median 80%, 75% and 75%, respectively, P=0.15). There was no significant interaction between the stimulation protocols and TORI for oocyte maturation. Conclusions: PPOS cycles do not seem to require a longer TORI than GnRH antagonist cycles.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.publisherscopeInternational
dc.description.volume48
dc.identifier.doi10.1016/j.rbmo.2023.103626
dc.identifier.eissn1472-6491
dc.identifier.issn1472-6483
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85181092573
dc.identifier.urihttps://doi.org/10.1016/j.rbmo.2023.103626
dc.identifier.urihttps://hdl.handle.net/20.500.14288/23052
dc.identifier.wos1152381400001
dc.keywordsChoriogonadotropin alfa (drug)
dc.keywordsChorionic gonadotropin
dc.keywordsFollitropin
dc.keywordsGonadorelin
dc.keywordsGonadorelin agonist
dc.keywordsGonadotropin
dc.keywordsHuman menopausal gonadotropin
dc.keywordsTriptorelin
dc.keywordsChorionic gonadotropin
dc.keywordsGestagen
dc.keywordsGonadorelin
dc.keywordsGonadorelin antagonist
dc.keywordsHormone antagonist
dc.languageen
dc.publisherReproductive BioMedicine Online
dc.sourceReproductive BioMedicine Online
dc.subjectIn vitro fertilisation
dc.subjectOvulation induction
dc.subjectGonadotropin-releasing hormone
dc.titleShould the trigger to oocyte retrieval interval be different in progestin-primed ovarian stimulation cycles?
dc.typeJournal article
dspace.entity.typePublication
local.contributor.kuauthorAta, Mustafa Barış
local.contributor.kuauthorÇakar, Aysu
local.contributor.kuauthorTürkgeldi, Engin
local.contributor.kuauthorYıldız, Şule
local.contributor.kuauthorKeleş, İpek
local.contributor.kuauthorKalafat, Erkan

Files